DePuy Synthes collaborated with LifeNet Health to introduce the ViviGen Cellular Bone Matrix, a differentiated cellular allograft to repair or reconstruct musculoskeletal defects.
Here are five things to know about the ViviGen Cellular Bone Matrix:
1. Robert Masson, MD, performed the first procedure implanting ViviGen earlier this year.
2. The implant is a human cells, tissues and cellular and tissue-based product comprised of cryopreserved live, viable sells with a cortical cancellous bone matrix and demineralized bone.
3. LifeNet Health has conducted reserach over the past four years to enable the processing of ViviGen to maintain cell viability.
4. ViviGen has been utilized in a variety of spinal fusion surgeries since it became available.
5. DePuy Synthes Biomaterials have an exclusive worldwide agreement to market and promote ViviGen, developed by LifeNet.
"The science behind ViviGen, combined with the intraoperative flexibility it provides drove me to try it initially," said Kennedy Yalamanchili, MD, of Christiniana Care Hospital in Newark, Del. "My experience early on has shown that ViviGen has desirable handling characteristics and is an appropriate alternative to taking the patient's own bone for many of my spinal procedures."
More articles on devices:
Zimmer Spine's growth: 12 new product launches
Exactech to launch Octane Elevate PEEK spacer system
Precision Spine to introduce new products, expansion at NASS meeting